This episode explores clozapine-induced orthostasis and offers management strategies such as slow titration and fluid intake. The use of fludrocortisone for persistent orthostasis is also discussed.
Orthostasis caused by clozapine can limit titration and hinder patients from reaching therapeutic levels.
Fludrocortisone can be used to treat persistent orthostasis in patients on clozapine, but caution and monitoring of electrolytes are necessary.
Deep dives
Orthostasis: A Significant Side-Effect of Clozapine
Clozapine, an antipsychotic medication, has a high affinity for alpha-1 adrenergic receptors, which can cause orthostasis. This side effect, which is not always dose-dependent, affects around 20% of patients. Orthostasis can limit clozapine titration and prevent patients from reaching therapeutic levels. To manage orthostasis, practitioners should use the slowest titration that seems reasonable and encourage fluid intake. They should also minimize other medications that contribute to orthostasis risk, like other alpha-1 antagonists and benzodiazepines. Efficient management strategies and regular monitoring of blood pressure can aid in addressing orthostasis.
Persistent Orthostasis: Treatment Options
Despite preventive measures, persistent orthostasis may occur. In such cases, fludrocortisone, a volume expander, can be used to treat orthostasis and allow further titration of clozapine. Fludrocortisone is a potent mineral corticoid that increases water and sodium reabsorption. However, it should be used cautiously, and serum potassium levels should be monitored due to its impact on electrolytes. Communication with primary care providers is crucial to adjust anti-hypertensive medications and recognize other medications that contribute to orthostasis risk. Overall, the aim is to minimize orthostasis and enhance the effectiveness of clozapine treatment.
In this episode, we discuss the causes of clozapine-induced orthostasis. Although some patients may develop tolerance, it can limit titration and potentially obstruct patients from reaching the plasma level where they respond well to the medication. There are practical management strategies for orthostasis, including slow titration based on patient complaints and encouraging fluid intake, among others.
Faculty: Jonathan Meyer, M.D. Host: Richard Seeber, M.D.